F175-1250 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide

F175-1250 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide
F175-1250 Screening compound: N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F175-1250
N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F175-1250

Molecular Formula

C25H28N4O6S (C25 H28 N4 O6 S)

Compound Name

N-[(2H-1,3-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide

IUPAC name

N-[(2H-13-benzodioxol-5-yl)methyl]-1-[5-(5-ethyl-124-oxadiazol-3-yl)-2-methylbenzenesulfonyl]piperidine-4-carboxamide

SMILES

CCc1nc(-c2cc(S(N(CC3)CCC3C(NCc(cc3)cc4c3OCO4)=O)(=O)=O)c(C)cc2)no1

InChI

InChI=1S/C25H28N4O6S/c1-3-23-27-24(28-35-23)19-6-4-16(2)22(13-19)36(31,32)29-10-8-18(9-11-29)25(30)26-14-17-5-7-20-21(12-17)34-15-33-20/h4-7,12-13,18H,3,8-11,14-15H2,1-2H3,(H,26,30)

InChI Key

AXKWMZWKRZTWAW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27106859

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

512.59

Hydrogen Bond Acceptors Count

12.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.850

Distribution Coefficient, logD

3.850

Water Solubility, LogSw

-3.82

Polar Surface Area

104.821

Acid Dissociation Constant (pKa)

14.07

Base Dissociation Constant (pKb)

-0.47

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

40.00

F175-1250 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

CORONAVIRUS Library (20774 compounds)

PLpro Library (6343 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F175-1250 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F175-1250?
Check Price and Availability of F175-1250, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F175-1250 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F175-1250
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F175-1250
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F175-1250 available by request